Gestational Diabetes

Study findings on gestational diabetes are outlined in reports from University of Toronto

Published in Biotech Business Week, January 12th, 2009

"Metformin is an effective alternative to insulin for nonpregnant women with type 2 diabetes mellitus; however, it has not yet been studied in the setting of gestational diabetes mellitus (GDM). Concerns have been raised about the effect of metformin on fetal development, particularly because it crosses the placenta," investigators in Toronto, Canada report.

"In this Practice Point commentary, I discuss the findings of an open-label, multicenter, prospective trial conducted by Rowan et al., in which women with GDM were randomly allocated to receive metformin (plus insulin when necessary) or insulin alone. The rate of a composite neonatal outcome and the efficiency of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2009-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry